|
Originally published In Press as doi:10.1074/jbc.M200129200 on July 30, 2002
J. Biol. Chem., Vol. 277, Issue 40, 37212-37218, October 4, 2002
p38 and Activating Transcription Factor-2 Involvement in
Osteoblast Osmotic Response to Elevated Extracellular Glucose*
Majd
Zayzafoon,
Sergiu
Botolin, and
Laura R.
McCabe
From the Department of Physiology, Michigan State University,
East Lansing, Michigan 48824
Poorly controlled or untreated type I diabetes
mellitus is characterized by hyperglycemia and is associated with
decreased bone mass and osteoporosis. We have demonstrated that
osteoblasts are sensitive to hyperglycemia-associated osmotic stress
and respond to elevated extracellular glucose or mannitol by increasing
c-jun and collagen I expression. To determine
whether MAPKs are involved in this response, MC3T3-E1 osteoblasts
were treated with 16.5 mM glucose, mannitol, or contrast
dye for 1 h. Immunoblotting of phosphorylated p38 demonstrated
activation of p38 MAPK by hyperosmotic stress in vitro and
in vivo. Activation peaked at 20 min, remained detectable
after 24 h, and was protein kinase C-independent. Activating transcription factor-2 (ATF-2) activation followed the same pattern as
phospho-p38. Transactivation of cAMP response element (CRE)- and
c-jun promoter (containing a CRE-like element)-reporter
constructs increased following hyperosmotic treatment. SB 203580 (a p38 MAPK inhibitor) blocked ATF-2 phosphorylation, CRE
transactivation, and c-jun promoter activation.
Hyperosmotic activation of collagen I promoter activity was also
inhibited by SB 203580, consistent with the involvement of
c-jun in collagen I up-regulation. Therefore, we propose
that hyperglycemia-induced increases in p38 MAPK activity and ATF-2
phosphorylation contribute to CRE activation and modulation of
c-jun and collagen I expression in osteoblasts.
*
This work was supported by grants from the American Diabetes
Association and the National Aeronautics and Space Administration.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Physiology,
Michigan State University, 2201 Biomedical & Physical Sciences Bldg.,
East Lansing, MI 48824. Tel.: 517-355-6475, ext. 1156; Fax:
517-355-5125; E-mail: mccabel@msu.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Irwin, H. V. Lin, K. J. Motyl, and L. R. McCabe
Normal Bone Density Obtained in the Absence of Insulin Receptor Expression in Bone
Endocrinology,
December 1, 2006;
147(12):
5760 - 5767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ohnishi, G. Hasegawa, M. Yamasaki, H. Obayashi, M. Fukui, T. Nakajima, Y. Ichida, H. Ohse, S.-i. Mogami, T. Yoshikawa, et al.
Integrin-linked kinase acts as a pro-survival factor against high glucose-associated osmotic stress in human mesangial cells
Nephrol. Dial. Transplant.,
July 1, 2006;
21(7):
1786 - 1793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zayzafoon, K. Fulzele, and J. M. McDonald
Calmodulin and Calmodulin-dependent Kinase II{alpha} Regulate Osteoblast Differentiation by Controlling c-fos Expression
J. Biol. Chem.,
February 25, 2005;
280(8):
7049 - 7059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zayzafoon, W. E. Gathings, and J. M. McDonald
Modeled Microgravity Inhibits Osteogenic Differentiation of Human Mesenchymal Stem Cells and Increases Adipogenesis
Endocrinology,
May 1, 2004;
145(5):
2421 - 2432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zayzafoon, S. A. Abdulkadir, and J. M. McDonald
Notch Signaling and ERK Activation Are Important for the Osteomimetic Properties of Prostate Cancer Bone Metastatic Cell Lines
J. Biol. Chem.,
January 30, 2004;
279(5):
3662 - 3670.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|